Phase 1b trial of CRS-207, immunotherapy vaccine, with chemotherapy for malignant pleural mesothelioma
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, David Carbone, MD, PhD, from The Ohio State University Wexner Medical Center, Columbus, OH, discu...
Author: VJOncology
Added: 06/06/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Asbestosis | Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Conferences | Immunotherapy | Lung Cancer | Mesothelioma | Vaccines